Fidasimtamab, referred to as DLTV – 1504, represents an innovative strategy in the battle against multiple myeloma. It is a dual-specific molecule designed to simultaneously engage CD3-positive immune https://fidasimtamabliquid490536.blognody.com/52740289/fidasimtamab-this-promising-hope-in-advanced-myeloma-treatment